V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20205826 | 20088483 | 1.82 | 0 | Palliative (P) | 2018-01-23 | 2018-02-06 | BENDAMUSTINE + RITUXIMAB | 02 | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 100959755 |
| 20205829 | 20088484 | 1.69 | 104 | Adjuvant (A) | 2018-07-07 | 2018-07-18 | R GCVP | 02 | N | ACTICCA-1 TRIAL | 101085882 |
| 20205942 | 20088486 | 0 | 158 | Palliative (P) | 2016-11-08 | 2016-11-08 | STAR TRIAL | null | N | HYDROXYCARBAMIDE | 100056600 |
| 20205943 | 20088487 | null | 53.5 | Adjuvant (A) | 2019-01-18 | 2019-01-18 | Irinotecan 14day | N | N | DOXORUBICIN | 100289612 |
| 20205947 | 20088488 | 1.53 | 49.2 | null | 2018-06-17 | 2018-07-06 | ARISTOTLE TRIAL | null | N | HYDROXYCARBAMIDE | 100507003 |
| 20205960 | 20088489 | 1.42 | 52.7 | 03 | 2018-09-08 | 2018-10-10 | null | 02 | N | SCOPE2 TRIAL | 100832654 |
| 20206003 | 20088490 | null | 65.5 | Palliative (P) | 2019-07-27 | 2019-07-27 | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 02 | N | ECARBOX | 100633962 |
| 20206048 | 20088491 | 1.55 | 92.3 | 03 | 2013-03-09 | 2019-10-19 | CISPLATIN + RT | 01 | N | SCOPE 1 TRIAL | 101257517 |
| 20206119 | 20088492 | 1.58 | 67 | Palliative (P) | 2017-10-20 | 2017-11-08 | DABRAFENIB + TRAMETINIB | 02 | N | CHOP R | 100637538 |
| 20206191 | 20088493 | 1.68 | 55.6 | Palliative (P) | null | 2019-05-12 | PEMBROLIZUMAB | 01 | N | CAPECITABINE + OXALIPLATIN + RT | 100692362 |
| 20206326 | 20088494 | 1.72 | 73 | 03 | 2020-04-21 | 2020-05-03 | PHITT C SIOPEL-3HR | 02 | N | NEO-AEGIS TRIAL | 101105685 |
| 20206363 | 20088495 | 1.74 | 94.5 | 03 | 2018-06-08 | 2018-06-19 | MIC | 02 | N | ACELARATE TRIAL | 100223109 |
| 20206378 | 20088496 | 1.65 | 43.2 | 03 | 2020-08-26 | 2020-08-28 | PHITT B or C Cisplatin | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100834138 |
| 20206443 | 20088497 | 1.68 | 78.8 | 03 | 2018-08-26 | 2018-08-28 | NAB PACLITAXEL | null | N | BORTEZOMIB | 101450822 |
| 20206480 | 20088498 | null | 9.5 | 03 | null | 2018-03-13 | SCOPE 2 TRIAL | null | N | SUNITINIB | 100364677 |
| 20206498 | 20088499 | 1.73 | 77.9 | 03 | 2018-04-16 | 2018-04-16 | ESPAC-4 TRIAL | 02 | N | RALTITREXED | 101349727 |
| 20206530 | 20088501 | 1.78 | 79.8 | 03 | null | 2018-07-29 | Pazopanib | 01 | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 101395576 |
| 20206546 | 20088502 | 1.74 | 88 | Palliative (P) | 2017-06-01 | 2017-06-01 | Carboplatin + Pemetrexed | 02 | N | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 100757014 |
| 20206644 | 20088503 | 1.57 | null | 03 | 2019-06-05 | 2019-06-05 | null | 02 | null | PEMBROLIZUMAB | 101417379 |
| 20206746 | 20088504 | 1.7 | 99 | null | 2018-11-23 | 2018-11-25 | CARBOPLATIN + FLUOROURACIL | 02 | N | ECARBOX | 101251309 |
| 20206813 | 20088505 | 1.6 | 55.1 | Palliative (P) | 2018-06-01 | 2018-06-03 | PHITT C SIOPEL-3HR | 02 | N | NIVOLUMAB | 101023740 |
| 20206819 | 20088506 | 1.61 | 82 | null | 2018-04-15 | 2018-04-20 | OXALIPLATIN | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101834207 |
| 20206848 | 20088507 | null | 15.4 | Neo-adjuvant (N) | 2018-06-07 | 2018-06-14 | Rituximab | N | Y | NAB-PACLITAXEL | 100260014 |
| 20206885 | 20088508 | 1.75 | 53 | Adjuvant (A) | 2017-07-25 | 2017-07-25 | Radium 223 | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100930268 |
| 20206894 | 20088510 | null | 12.3 | Palliative (P) | 2018-11-21 | 2018-11-21 | null | 02 | N | CISPLATIN + FLUOROURACIL + RT | 100095617 |
| 20206959 | 20088511 | 1.78 | 74.19 | 03 | null | 2018-09-08 | Doxorubin 50mg/m2 | N | N | TRASTUZUMAB EMTANSINE | 101491245 |
| 20206966 | 20088512 | 1.78 | 59.4 | 03 | 2019-06-03 | 2019-06-13 | FEC | 02 | N | ARSENIC TRIOXIDE + TRETINOIN | 100343657 |
| 20207149 | 20088513 | 1.7 | 68 | 03 | 2018-12-30 | 2018-12-30 | ACTICCA-1 Trial | N | N | HEPATOBLASTOMA SR CISPLATIN | 100672045 |
| 20207194 | 20088514 | 1.63 | 68 | 03 | 2018-12-23 | 2019-01-08 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 100428520 |
| 20207217 | 20088515 | null | 62 | Adjuvant (A) | 2017-09-10 | 2017-09-10 | Abiraterone | 02 | null | ACELARATE TRIAL | 100151593 |
| 20207231 | 20088516 | 1.9 | 58.4 | Palliative (P) | 2017-04-06 | 2017-04-10 | CARBOPLATIN + FLUOROURACIL | 02 | N | PLATFORM TRIAL | 100402828 |
| 20207338 | 20088517 | 1.52 | 92 | Palliative (P) | 2018-01-04 | 2018-01-05 | null | 02 | N | BALLAD TRIAL | 100323762 |
| 20207341 | 20088518 | 1.63 | 105 | 03 | 2017-08-11 | 2017-08-11 | Hydroxycarbamide | 02 | N | DOCETAXEL | 100844603 |
| 20207351 | 20088519 | 1.54 | 76.1 | Palliative (P) | null | 2019-03-05 | Trifluridine + Tipiracil | N | N | SCOPE2 TRIAL | 101667709 |
| 20207380 | 20088520 | 1.81 | 58.15 | 03 | 2021-12-01 | 2021-12-24 | Panitumumab | 02 | N | ACELARATE TRIAL | 101626298 |
| 20207423 | 20088521 | 1.66 | 119 | Palliative (P) | 2018-07-20 | 2018-07-26 | CISPLATIN + RALTITREXED | 02 | null | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100383304 |
| 20207427 | 20088522 | 1.85 | 0 | Palliative (P) | 2019-12-22 | 2019-12-29 | null | null | Y | FCIST | 100064402 |
| 20207452 | 20088524 | 0 | 0 | Adjuvant (A) | 2016-04-15 | 2016-05-02 | Abiraterone | 02 | Y | CAPITAL TRIAL | 100696936 |
| 20207453 | 20088525 | 1.6 | 71.4 | Palliative (P) | null | 2018-07-14 | Atezolizumab | 2 | N | CLADRIBINE | 101647470 |
| 20207491 | 20088527 | 1.69 | 73.45 | Palliative (P) | 2012-09-22 | 2015-08-03 | PACLITAXEL | 02 | N | IBRUTINIB | 100213608 |
| 20207538 | 20088528 | 1.63 | 69.2 | Palliative (P) | 2017-10-14 | 2017-10-31 | FCiSt | 02 | N | BACILLUS CALMETTE-GUERIN | 101789982 |
| 20207633 | 20088529 | 1.7 | 76 | Palliative (P) | 2017-12-24 | 2018-01-03 | PEMBROLIZUMAB | 01 | N | BEVACIZUMAB + OXALIPLATIN + MdG | 101468877 |
| 20207672 | 20088530 | 1.57 | 62 | Palliative (P) | 2017-03-11 | 2017-03-19 | VISMODEGIB | 02 | Y | CAPECITABINE + STREPTOZOCIN | 101483646 |
| 20207716 | 20088531 | null | null | 03 | 2017-01-04 | 2017-01-12 | ECarboX | 02 | null | ATEZOLIZUMAB | 101534386 |
| 20207916 | 20088532 | 1.54 | 63.6 | null | 2019-06-09 | 2019-06-10 | EOF | 02 | N | CISPLATIN + VINORELBINE | 100265158 |
| 20207941 | 20088533 | 0 | 0 | Palliative (P) | 2019-08-29 | 2019-09-11 | Radium 223 | 02 | N | CAPE + CETUXIMAB + OXALIPLATIN | 100556932 |
| 20208048 | 20088534 | 1.62 | 53.25 | null | 2017-08-13 | 2017-08-20 | Cape+Cetuximab+Oxalip (2 wk) Maint | 01 | N | RALTITREXED | 101311813 |
| 20208052 | 20088535 | 1.88 | 70.2 | 03 | 2019-02-09 | 2019-03-23 | Hydroxycarbamide | 01 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100104189 |
| 20208057 | 20088536 | 1.51 | 59.85 | 03 | 2016-12-30 | 2016-12-30 | FCarboSt | 02 | N | GO2 TRIAL | 100390607 |
| 20208087 | 20088537 | null | 68.5 | Adjuvant (A) | 2017-09-20 | 2017-09-20 | Docetaxel 75mg/m2 (21 day) | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 101381010 |